Insider · CIK 0001355850

Eramian Daniel G

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001355850

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-09-20	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−15K sh	$2.68	−$40.2K	354,350
2012-08-24	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−41.6K sh	$0.39	−$16.2K	1,900,203
2012-08-24	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−23.4K sh	$0.39	−$9,165.822	1,876,761
2012-08-24	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−20K sh	$0.39	−$7,840	1,856,761
2012-08-24	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−10K sh	$0.40	−$4,000	1,846,761
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−3,000 sh	$0.57	−$1,704	1,988,761
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−200 sh	$0.57	−$113.8	1,988,561
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−6,800 sh	$0.57	−$3,876	1,981,761
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−9,731 sh	$0.57	−$5,556.401	1,972,030
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−269 sh	$0.57	−$153.868	1,971,761
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−10K sh	$0.58	−$5,760	1,961,761
2012-06-28	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−20K sh	$0.58	−$11.6K	1,941,761
2012-06-27	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+27.4K sh	—	—	1,991,761
2012-03-21	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−7,593 sh	$1.31	−$9,946.83	1,964,346
2012-01-03	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+1.21M sh	—	—	1,971,939
2011-12-31	CTI BIOPHARMA CORPD Disposition to Issuer	EVP, Corporate Communications	DDisposition to Issuer	−498K sh	—	—	759,986
2011-11-29	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+506K sh	—	—	1,258,315
2011-09-21	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−7,593 sh	$1.02	−$7,744.86	752,627
2011-03-25	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−106K sh	$0.38	−$40.1K	4,311,320
2011-03-21	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+250K sh	—	—	4,666,899
2011-03-21	CTI BIOPHARMA CORPRestricted Stock UnitsA Award	EVP, Corporate Communications	AAward	+250K sh	—	—	250,000
2010-12-27	CTI BIOPHARMA CORPD Disposition to Issuer	EVP, Corporate Communications	DDisposition to Issuer	−8,000 sh	—	—	4,416,899
2010-12-16	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−250K sh	$0.36	−$90K	4,424,899
2010-07-12	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+2.99M sh	—	—	4,674,899
2010-03-25	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−106K sh	$0.67	−$70.7K	1,684,916
2009-12-31	CTI BIOPHARMA CORPD Disposition to Issuer	EVP, Corporate Communications	DDisposition to Issuer	−5,040 sh	—	—	1,790,495
2009-12-15	CTI BIOPHARMA CORPPerformance RightsA Award	EVP, Corporate Communications	AAward	+1.32M sh	—	—	1,320,752
2009-11-10	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+870K sh	—	—	2,112,668
2009-11-10	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−317K sh	$0.99	−$314K	1,795,535
2009-10-22	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−27.3K sh	$1.11	−$30.3K	1,242,618
2009-09-25	CTI BIOPHARMA CORPS Sale	EVP, Corporate Communications	SSale	−104K sh	$1.25	−$130K	1,269,955
2009-07-31	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+645K sh	—	—	1,609,295
2009-07-31	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−235K sh	$1.48	−$348K	1,374,231
2009-07-31	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+645K sh	—	—	1,609,295
2009-07-31	CTI BIOPHARMA CORPF Tax Payment	EVP, Corporate Communications	FTax Payment	−235K sh	$1.48	−$348K	964,398
2009-03-25	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+869K sh	—	—	964,398
2008-10-22	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+75K sh	—	—	95,431
2006-06-23	CTI BIOPHARMA CORPA Award	EVP, Corporate Communications	AAward	+15K sh	—	—	55,000
2006-06-22	CTI BIOPHARMA CORPIncentive Stock Option (right to buy)A Award	EVP, Corporate Communications	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Sep 214
Eramian Daniel G0000891293-12-000053
SEC(opens sec.gov)
Aug 244
Eramian Daniel G0000891293-12-000049
SEC(opens sec.gov)
Jun 294
Eramian Daniel G0000891293-12-000040
SEC(opens sec.gov)
Mar 234
Eramian Daniel G0000891293-12-000015
SEC(opens sec.gov)
Jan 44
Eramian Daniel G0000891293-12-000009
SEC(opens sec.gov)
Dec 14
Eramian Daniel G0000891293-11-000071
SEC(opens sec.gov)
Sep 234
Eramian Daniel G0000891293-11-000047
SEC(opens sec.gov)
Apr 84/A
Eramian Daniel G0000891293-11-000037
SEC(opens sec.gov)
Mar 254
Eramian Daniel G0000891293-11-000022
SEC(opens sec.gov)

Companies

CTI BIOPHARMA CORPEVP, Corporate Communications

Address

501 ELLIOTT AVE. W. SUITE #400

SEATTLE, WA, 98119